SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
12-Mar-20 7:01 PM View: | Invivo Therapeutics Holding... (NVIV) | 10-Mar-20 | Purchase | 3,636 | -- | -- | 230% 1.58K to 5.22K | |
27-Sep-19 7:38 PM View: | Invivo Therapeutics Holding... (NVIV) | 25-Sep-19 | Grant | 47,500 | -- | -- | 100% 0 to 47.5K | |
06-Dec-18 4:46 PM View: | icad Inc. (ICAD) | 05-Dec-18 | Payment of Exercise | 4,909 | $4.08 | $20,028.70 | (4%) 122.76K to 117.85K | (227%) |
02-Apr-18 5:54 PM View: | icad Inc. (ICAD) | 30-Mar-18 | Grant | 58,333 | $3.08 | $179,666.00 | 29% 200.66K to 259.0K | 329% |
02-Apr-18 5:54 PM View: | icad Inc. (ICAD) | 30-Mar-18 | Payment of Exercise | 6,735 | $3.08 | $20,743.80 | (3%) 259.0K to 252.26K | (329%) |
28-Mar-18 4:31 PM View: | icad Inc. (ICAD) | 22-Mar-18 | Grant | 25,000 | -- | -- | 54% 46.16K to 71.17K | |
07-Dec-17 1:56 PM View: | icad Inc. (ICAD) | 05-Dec-17 | Payment of Exercise | 5,409 | $3.52 | $19,039.70 | (10%) 51.57K to 46.16K | (275%) |
08-May-17 4:22 PM View: | icad Inc. (ICAD) | 04-May-17 | Grant | 1,574 | -- | -- | 3% 50.0K to 51.57K | |
06-Dec-16 1:06 PM View: | icad Inc. (ICAD) | 05-Dec-16 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
20-Dec-12 5:10 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 276,012 | $8.00 | $2,208,100.00 | (100%) 276.01K to 0 | 0% |
13-Nov-12 2:05 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 13-Nov-12 | Option Exercise | 7,500 | $1.60 | $12,000.00 | 3% 268.51K to 276.01K | |
11-May-12 9:40 AM View: | DUSA Pharmaceuticals Inc. (DUSA) | 09-May-12 | Payment of Exercise | 1,030 | $6.13 | $6,313.90 | (< 1%) 269.54K to 268.51K | (30%) |
15-Mar-12 1:51 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 13-Mar-12 | Payment of Exercise | 2,980 | $5.86 | $17,462.80 | (1%) 272.52K to 269.54K | (36%) |
09-Mar-12 2:26 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 08-Mar-12 | Grant | 130,000 | -- | -- | 46% 285.04K to 415.04K | |
09-Mar-12 2:26 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 07-Mar-12 | Payment of Exercise | 5,151 | $6.05 | $31,163.60 | (2%) 290.19K to 285.04K | (32%) |
07-Mar-12 3:40 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 05-Mar-12 | Payment of Exercise | 3,329 | $4.65 | $15,479.90 | (2%) 151.0K to 147.67K | (71%) |
13-May-11 2:46 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 12-May-11 | Option Exercise | 42,550 | $1.53 | $65,161.00 | 28% 151.0K to 193.55K | |
13-May-11 2:46 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 12-May-11 | Market Option Sale | 42,550 | $5.94 | $252,754.00 | (22%) 193.55K to 151.0K | (34%) |
11-May-11 12:05 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 09-May-11 | Payment of Exercise | 1,032 | $5.80 | $5,985.60 | (< 1%) 152.03K to 151.0K | (37%) |
14-Mar-11 10:38 AM View: | DUSA Pharmaceuticals Inc. (DUSA) | 13-Mar-11 | Payment of Exercise | 2,985 | $4.15 | $12,387.80 | (2%) 155.02K to 152.03K | (91%) |
08-Mar-11 1:42 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 07-Mar-11 | Grant | 65,000 | -- | -- | 36% 180.04K to 245.04K | |
08-Mar-11 1:42 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 04-Mar-11 | Payment of Exercise | 3,334 | $3.95 | $13,169.30 | (2%) 183.37K to 180.04K | (101%) |
10-May-10 4:32 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 09-May-10 | Payment of Exercise | 1,032 | $2.01 | $2,074.32 | (1%) 94.39K to 93.35K | (294%) |
16-Mar-10 10:12 AM View: | DUSA Pharmaceuticals Inc. (DUSA) | 12-Mar-10 | Payment of Exercise | 3,215 | $1.78 | $5,722.70 | (3%) 97.6K to 94.39K | (346%) |
08-Mar-10 1:40 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 05-Mar-10 | Grant | 42,000 | -- | -- | 76% 55.6K to 97.6K | |
17-Mar-09 10:13 AM View: | DUSA Pharmaceuticals Inc. (DUSA) | 13-Mar-09 | Grant | 37,600 | -- | -- | 209% 18.0K to 55.6K | |
19-Aug-08 11:32 AM View: | DUSA Pharmaceuticals Inc. (DUSA) | 18-Aug-08 | Grant | 5,000 | $2.00 | $10,000.00 | 6% 78.25K to 83.25K | 947% |
12-May-08 4:55 PM View: | DUSA Pharmaceuticals Inc. (DUSA) | 09-May-08 | Grant | 13,000 | -- | -- | 100% 0 to 13.0K |